Login / Signup

Imatinib as a Tool Against COVID-19: A Balancing Act Between Effectiveness and Cardiac Safety.

Luigi SpadaforaMarco BernardiGiuseppe Biondi ZoccaiMariangela Peruzzi
Published in: Journal of cardiovascular pharmacology (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • randomized controlled trial
  • systematic review
  • chronic myeloid leukemia
  • left ventricular
  • respiratory syndrome coronavirus